Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
In Taiwan, chronic kidney disease (CKD) is highly prevalent and traditional Chinese medicine (TCM) is one of the most commonly used complementary medicines. To date, little information is available on the utilization patterns for TCM among CKD patients, particularly those with late stage CKD. We conducted a cross-sectional hospital-based study to investigate this issue. In this study, late stage CKD patients were identified by ICD-9-CM codes: 585 and 586, and only CKD stage 3b, 4 and 5 patients were included in the analysis. Clinical information was retrieved from the electronic medical records database from January, 1, 2006 to December, 31, 2011. Among a total of 8,459 patients, 408 TCM users and 8,051 non-TCM users were identified and their data were analyzed. We found that TCM users were almost four times more likely to be older than 55 years than non-TCM users, after controlling for the other covariates (adjusted odds ratio [aOR]: 3.98, 95% confidence interval [CI]:[2.33, 6.81]). They were also less likely to have diabetes (aOR: 0.48), hypertension (aOR: 0.62) or gout (aOR: 0.62). Among all disease conditions, late stage CKD patients with neoplasms had the highest tendency to seek TCM treatment compared to non-neoplasm CKD patients (aOR: 5.39, 95% CI: [4.64, 6.26]). Among all TCM users, internal medicine outpatient services (providing CHMs only) is more frequently used than acupuncture/massage outpatient services (3,476 vs. 320 visits). Jia-Wei-Xiao-Yao-San (JWXYS) was the most commonly prescribed Chinese herbal medicine (CHM) for late CKD patients (36.2% of 4,494 prescriptions), followed by Bu-Yang-Huan-Wu-Tang (BYHWT)
In Taiwan, chronic kidney disease (CKD) is highly prevalent and traditional Chinese medicine (TCM) is one of the most commonly used complementary medicines. To date, little information is available on the utilization patterns for TCM among CKD patients, particularly those with late stage CKD. We conducted a cross-sectional hospital-based study to investigate this issue. In this study, late stage CKD patients were identified by ICD-9-CM codes: 585 and 586, and only CKD stage 3b, 4 and 5 patients were included in the analysis. Clinical information was retrieved from the electronic medical records database from January, 1, 2006 to December, 31, 2011. Among a total of 8,459 patients, 408 TCM users and 8,051 non-TCM users were identified and their data were analyzed. We found that TCM users were almost four times more likely to be older than 55 years than non-TCM users, after controlling for the other covariates (adjusted odds ratio [aOR]: 3.98, 95% confidence interval [CI]:[2.33, 6.81]). They were also less likely to have diabetes (aOR: 0.48), hypertension (aOR: 0.62) or gout (aOR: 0.62). Among all disease conditions, late stage CKD patients with neoplasms had the highest tendency to seek TCM treatment compared to non-neoplasm CKD patients (aOR: 5.39, 95% CI: [4.64, 6.26]). Among all TCM users, internal medicine outpatient services (providing CHMs only) is more frequently used than acupuncture/massage outpatient services (3,476 vs. 320 visits). Jia-Wei-Xiao-Yao-San (JWXYS) was the most commonly prescribed Chinese herbal medicine (CHM) for late CKD patients (36.2% of 4,494 prescriptions), followed by Bu-Yang-Huan-Wu-Tang (BYHWT)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.